US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 13.255
- +0.245+1.88%
Trading Apr 25 15:43 ET
15.01BMarket Cap-26510P/E (TTM)
13.260High12.800Low6.81MVolume12.770Open13.010Pre Close88.97MTurnover0.60%Turnover RatioLossP/E (Static)1.13BShares14.46552wk High2.00P/B14.92BFloat Cap7.08552wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM3.54%Amplitude3.107Historical Low13.072Avg Price1Lot Size
About Teva Pharmaceutical Industries Company
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Company Profile
SymbolTEVA
Company NameTeva Pharmaceutical Industries
Listing DateMay 30, 2012
Founded1901
CEOMr. Richard D. Francis
MarketNYSE
Employees37851
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address124 Dvora HaNevi'a Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6944020
Phone972-3-914-8213
Websitehttp://www.tevapharm.com
Company Executives
- Name
- Position
- Salary
- Richard D. Francis
- Director, President and Chief Executive Officer
- 25.71M
- Eric A Hughes
- Executive Vice President, Global R&D and Chief Medical Officer
- --
- Amir Weiss
- Senior Vice President and Chief Accounting Officer
- --
- Eli Kalif
- Executive Vice President and Chief Financial Officer
- 4.94M
- David R. McAvoy
- Executive Vice President and Chief Legal Officer
- --
- Eric Drape
- Executive Vice President, Global Operations
- 4.25M
- Richard Daniell
- Executive Vice President, European Commercial
- 5.16M
- Mark Sabag
- Executive Vice President, International Markets Commercial
- 3.73M
- Angus Grant
- Executive Vice President, Business Development
- --
- Christine Fox
- Executive Vice President, U.S. Commercial
- --
- Dr. Sol J. Barer,PhD
- Chairman of the Board
- 539.99K
- Professor Varda Shalev
- Independent Director
- 176.66K
- Dr. Perry D. Nisen
- Independent Director
- 327.87K
- Rosemary A. Crane
- Independent Director
- 330.00K
- Janet S. Vergis
- Independent Director
- 325.46K
- Roberto A. Mignone
- Independent Director
- 340.00K
- Amir Elstein
- Independent Director
- 340.00K
- Gerald M. Lieberman
- Independent Director
- 355.00K
- Dr. Tal Zaks, M.D.,PhD
- Independent Director
- 330.00K
- Professor Ronit Satchi-Fainaro
- Independent Director
- 315.25K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg